BIOBASE ExPlain(TM) Analysis Platform Selected for Top Honors

BIOBASE announced today that their ExPlain(TM) analysis platform
was chosen as Best of Show at Cambridge Healthtech Institute's 14(th)
Annual Molecular Medicine Conference in San Francisco, CA USA.

According to CHI, the event is the largest West Coast
bioinformatics conference. Over 2,400 pharmaceutical and biotech
attendees from more than 34 countries were asked to vote on the best
new products among 5 categories including Genomics, Proteomics,
Informatics, Chemistry and PreClinical. ExPlain(TM) was selected as
the top choice in the Informatics category.

In addition to traditional downstream pathway analysis of gene
expression, ExPlain(TM) offers a novel approach to identifying
potential targets. Drawing upon the combined power of other BIOBASE
databases TRANSFAC((R)), TRANSPATH((R)) and HumanPSD(TM), the
ExPlain(TM) platform offers the ability to exploit microarray data to
identify and visualize complex regulatory processes hidden in the
experimental data. According to Dr. Alexander Kel, Senior VP of
Research and Development at BIOBASE, "Researchers can conduct upstream
searches in the signal transduction network to discover common nodes
that explain the observed changes in gene expression." Information on
BIOBASE's ExPlain(TM) analysis platform is available at
www.biobase-international.com.

"This award is an excellent, independent endorsement by conference
attendees on the power of our ExPlain(TM) platform and its potential
for our customers. We are very pleased to receive this honor" said
Michael Tysiak, CEO of BIOBASE.

About BIOBASE GmbH

BIOBASE (www.biobase-international.com), based in Wolfenbuttel
(Germany), with branch offices in Beverly, MA (USA) and Bangalore
(India) is the leading provider of expertly-curated biological
databases and sophisticated software tools. The BIOBASE Knowledge
Library includes but is not limited to the TRANSFAC((R)),
TRANSPATH((R)), YPD(TM)and HumanPSD(TM) databases. In combination with
the system-biological analysis platform ExPlain(TM), molecular
networks can be investigated and key molecules can be efficiently
identified. BIOBASE also provides a growing portfolio of databases of
third parties, generally academic developers, such as BRENDA((R)) or
HGMD((R)). More than 600 customers now own licenses to BIOBASE
databases. For more information, please visit our website at
www.biobase-international.com.

More on Cambridge Healthtech Institute (CHI) is available at
www.healthtech.com